KBKarl-Friedrich Becker

Karl-Friedrich Becker

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years

Recognitions

Top Cited Scholar (2026)

Karl-Friedrich Becker has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Supplemental Table 1 from Epidemiologic Risk Factors in a Comparison of a Barrett Esophagus Registry (BarrettNET) and a Case–Control Population in Germany

    by Melissa Schmidt, Donna P. Ankerst, Yiyao Chen, Maria Wiethaler, Julia Slotta-Huspenina, Karl-Friedrich Becker, Julia Horstmann, Florian Kohlmayer, Andreas Lehmann, Birgit Linkohr, et al.

  • Development of a Scalable AiP Module for mmWave 5G MIMO Applications Based on a Double Molded FOWLP Approach

    by Tanja Braun, Thi Huyen Le, Marco Rossi, Ivan Ndip, Ole Holck, Karl-Friedrich Becker, Mathias Bottcher, Michael Schiffer, Rolf Aschenbrenner, Friedrich Muller, et al.

    In the last years, the increasing demand for ever higher data rates in wireless communication has exposed the limits of current sub-6 GHz communication systems and pushed the technology towards the exploration of the mmWave frequency spectrum. In particular, 3 frequency bands have been licensed at 26 GHz, 28 GHz and 39 GHz for the new generation of mobile communication (5G), each exhibiting as much as 3 GHz of operational bandwidth. However, systems operating at mmWave have to cope with much higher free space losses then in the sub-6 GHz frequency range. Moreover, the physical size of interconnects (chip-to-chip, chip-to-antenna) becomes comparable to the operating wavelength. Therefore, new packaging technologies are required, which allow implementing large antenna arrays for massive MIMO and short interconnects to minimize package losses. Within the funded project IPCEI “mmWave Modules” a scalable and reconfigurable module for mmWave 5G small cell base stations has been developed. In particular, the module measures and exhibits two dual-band patch antenna arrays for operation at 28 GHz and 39 GHz. Moreover, it may be easily upscaled for the deployment in base stations covering larger cells. Packaging technology is based on a double molded Fan-out Wafer Level Package (FOWLP) approach with integrated antenna-in-package (AiP) that has been adapted and evaluated. The Analog-Front-End-IC (AFE IC) has been packaged as a start in an RDLfirst FOWLP on 300 mm wafer size. Redistribution layers were built-up on a glass carrier consequently followed by plating of the through package vias [TPVs] for later front and backside package connection. The AFE IC is then assembled as a flip chip on the RDL and compression molding is used to underfill the flip chip ICs and overmold the wafer carrier in one step. A backgrinding step is applied to open the TPVs for further electrical connection. Direct metallization using seed layer sputtering, copper plating and subtractive etching is used to add a shielding layer on the mold cap. After debonding the wafer is overmolded a second time using compression molding again. The antenna is then directly metallized on the second mold cap connected by laser drilled and metallized vias to TPVs and shielding layer. Finally solder balls are attached and packages are separated by dicing. Focus of the development was the double mold process with the related warpage challenges, direct metallization on mold as well as antenna and via integration and alignment on the second mold layer. Besides the development of the entire package the AiP concept has been evaluated using a GHz/39 GHz dual-band antenna test structure considering the later double mold approach including an inner shielding layer, laser drilled through mold vias and direct metallized antenna on mold. Measured bandwidths of 1 GHz and 700 MHz and gains of 5.3 dBi and 6.2 dBi at 28 GHz and 39 GHz, respectively, prove the applicability of the proposed packaging technology for mmWave 5G applications. In summary the paper will describe the FOWLP package development for a mmWave 5G MIMO application with focus on a double mold approach with antenna-in-package application.


  • Open Access

    Stakeholder engagement to ensure the sustainability of biobanks: a survey of potential users of biobank services

    by Corinna Klingler, Magdaléna von Jagwitz-Biegnitz, Ronny Baber, Karl-Friedrich Becker, Edgar Dahl, Cornelius Eibner, Jörg Fuchs, Maike K. Groenewold, Mara Lena Hartung, Michael Hummel, et al.

    Biobanks are important infrastructures facilitating biomedical research. After a decade of rolling out such infrastructures, a shift in attention to the sustainability of biobanks could be observed in recent years. In this regard, an increase in the as yet relatively low utilisation rates of biobanks has been formulated as a goal. Higher utilisation rates can only be achieved if the perspectives of potential users of biobanks—particularly researchers not yet collaborating with biobanks—are adequately considered. To better understand their perspectives, a survey was conducted at ten different research institutions in Germany hosting a centralised biobank. The survey targeted potential users of biobank services, i.e. researchers working with biosamples. It addressed the general demand for biosamples, strategies for biosample acquisition/storage and reasons for/against collaborating with biobanks. In total, 354 researchers filled out the survey. Most interestingly, only a minority of researchers (12%) acquired their biosamples via biobanks. Of the respondents not collaborating with biobanks on sample acquisition, around half were not aware of the (services of the) respective local biobank. Those who actively decided against acquiring biosamples via a biobank provided different reasons. Most commonly, respondents stated that the biosamples required were not available, the costs were too high and information about the available biosamples was not readily accessible. Biobanks can draw many lessons from the results of the survey. Particularly, external communication and outreach should be improved. Additionally, biobanks might have to reassess whether their particular collection strategies are adequately aligned with local researchers’ needs.


  • Open Access

    Oncogenic Linear Collagen VI of Invasive Breast Cancer Is Induced by CCL5

    by Elizabeth Brett, Matthias Sauter, Éadaoin Timmins, Omid Azimzadeh, Michael Rosemann, Juliane Merl-Pham, Stefanie M. Hauck, Peter J. Nelson, Karl Friedrich Becker, Ilse Schunn, et al.

    The triple-negative breast tumor boundary is made of aligned, linear collagen. The pro-oncogenic impact of linear collagen is well established; however, its mechanism of formation is unknown. An in vitro analogue of the tumor border is created by a co-culture of MDA-MB-231 cells, adipose derived stem cells, and dermal fibroblasts. Decellularization of this co-culture after seven days reveals an extracellular matrix that is linear in fashion, high in pro-oncogenic collagen type VI, and able to promote invasion of reseeded cells. Further investigation revealed linear collagen VI is produced by fibroblasts in response to a paracrine co-culture of adipose derived stem cells and MDA-MB-231, which together secrete high levels of the chemokine CCL5. The addition of monoclonal antibody against CCL5 to the co-culture results in an unorganized matrix with dramatically decreased collagen VI. Importantly, reseeded cells do not exhibit pro-oncogenic behavior. These data illustrate a cellular mechanism, which creates linear extracellular matrix (ECM) in vitro, and highlight a potential role of CCL5 for building striated tumor collagen in vivo.


  • Lysate Preparation for Reverse Phase Protein Arrays

    by Karl-Friedrich Becker

    Protein lysates from a variety of sample materials, e.g., cell lines, serum, frozen tissues, formalin-fixed and paraffin-embedded (FFPE) tissues, and fine needle aspirates, are compatible with the analysis using reverse phase protein arrays (RPPAs). Due to this diversity of input material, lysate preparation is one of the critical steps for obtaining reliable RPPA results. The challenges include, but are not limited to, achieving complete solubilization, avoiding chemical or enzymatic protein modifications, and degradation. In this chapter, preparations of lysates for RPPA analysis are described, focusing on human tissue samples. Special emphasis is given to recently published ISO International Standards for the preanalytical phase.


  • Open Access

    A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily

    by Anil Korkut, Sobia Zaidi, Rupa S. Kanchi, Shuyun Rao, Nancy R. Gough, Andre Schultz, Xubin Li, Philip L. Lorenzi, Ashton C. Berger, Gordon Robertson, et al.


  • Top Cited Papers
    Open Access

    Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer

    by Yumeng Wang, Xiaoyan Xu, Dejan Maglic, Michael T. Dill, Kamalika Mojumdar, Patrick Kwok-Shing Ng, Kang Jin Jeong, Yiu Huen Tsang, Daniela Moreno, Venkata Hemanjani Bhavana, et al.


  • Top Cited Papers
    Open Access

    Comprehensive Characterization of Cancer Driver Genes and Mutations

    by Matthew H. Bailey, Collin Tokheim, Eduard Porta-Pardo, Sohini Sengupta, Denis Bertrand, Amila Weerasinghe, Antonio Colaprico, Michael C. Wendl, Jaegil Kim, Brendan Reardon, et al.


  • Top Cited Papers
    Open Access

    Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

    by André Kahles, Kjong-Van Lehmann, Nora C. Toussaint, Matthias Hüser, Stefan G. Stark, Timo Sachsenberg, Oliver Stegle, Oliver Kohlbacher, Chris Sander, Samantha J. Caesar-Johnson, et al.


  • Präanalytik und Biobanking

    by K.-F. Becker, J. Wipperfürth, E. Herpel

    Der Zugang zu gut charakterisierten menschlichen Bioproben ist eine der wichtigsten Voraussetzungen für die moderne biomedizinische Forschung. Biobanken spielen hier eine entscheidende Rolle, da sie entsprechende Bioproben für geplante Analysen zur Verfügung stellen. Hierfür müssen viele Störfaktoren, die die Qualität von Bioproben beeinflussen, beachtet werden. Neben logistischen, ethischen und datenschutzrechtlichen Aspekten sind hier v. a. präanalytische Variablen im Rahmen der Probengewinnung, Verarbeitung und Lagerung zu nennen. Im vorliegenden Paper werden daher die wichtigsten präanalytischen Einflussfaktoren systematisch dargestellt. Außerdem geben wir einen Überblick über aktuelle nationale und internationale Aktivitäten zur standardisierten Erfassung der präanalytischen Variablen, um deren Einfluss auf das Analyseergebnis besser zu verstehen und in Zukunft zu minimieren. Access to well-characterized human biosamples is one of the most important prerequisites for modern biomedical research. Biobanks play a decisive role here, as they provide corresponding biosamples for planned analyses. Many interfering factors influencing the quality of biosamples have to be taken into account. In addition to logistical, ethical, and data protection aspects, preanalytical variables in the context of sample acquisition, storage, and processing should be mentioned in particular. In this paper, therefore, the most important preanalytical influencing factors are presented systematically and an overview of current national and international activities for the standardized recording of these factors is provided with the goal of being able to better understand their influence on results and to minimize them in the near future.